Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial
- PMID: 20149360
- DOI: 10.1016/j.fertnstert.2009.12.070
Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial
Abstract
Fifty healthy women, aged 18-39 years with no known risk of ovarian hyperstimulation were treated with 100 or 150 μg corifollitropin alfa (dependent on body weight) in a long GnRH agonist protocol. At these doses, corifollitropin alfa initiated and supported growth of a large cohort of follicles during the first week of ovarian stimulation.
Copyright © 2010. Published by Elsevier Inc.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources